Education
About Us
Working with TipRanks
Follow Us
Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)
:2179
RESEARCH TOOLSreports
2179 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$6.51 - HK$9.80
Previous CloseN/A
Volume13.00K
Average Volume (3M)30.55K
Market Cap
HK$3.64B
Enterprise ValueHK$4.60B
Total Cash (Recent Filing)HK$448.31M
Total Debt (Recent Filing)HK$889.10M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.78
Shares Outstanding316,138,700
10 Day Avg. Volume26,050
30 Day Avg. Volume30,550
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$7.50Price Target Upside-1.32% Downside
Rating ConsensusHold
Number of Analyst Covering0
Jiangsu Recbio Technology Co., Ltd. Class H News
2179 FAQ
What was Jiangsu Recbio Technology Co., Ltd. Class H’s price range in the past 12 months?
Jiangsu Recbio Technology Co., Ltd. Class H lowest stock price was HK$6.51 and its highest was HK$9.80 in the past 12 months.
What is Jiangsu Recbio Technology Co., Ltd. Class H’s market cap?
Jiangsu Recbio Technology Co., Ltd. Class H’s market cap is HK$3.64B.
When is Jiangsu Recbio Technology Co., Ltd. Class H’s upcoming earnings report date?
Jiangsu Recbio Technology Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2026 which is in 187 days.
How were Jiangsu Recbio Technology Co., Ltd. Class H’s earnings last quarter?
Jiangsu Recbio Technology Co., Ltd. Class H released its earnings results on Aug 29, 2025. The company reported -HK$0.776 earnings per share for the quarter, the consensus estimate of -HK$0.776 by HK$0.
Is Jiangsu Recbio Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Jiangsu Recbio Technology Co., Ltd. Class H’s price is currently Overvalued.
Does Jiangsu Recbio Technology Co., Ltd. Class H pay dividends?
Jiangsu Recbio Technology Co., Ltd. Class H does not currently pay dividends.
What is Jiangsu Recbio Technology Co., Ltd. Class H’s EPS estimate?
Jiangsu Recbio Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jiangsu Recbio Technology Co., Ltd. Class H have?
Jiangsu Recbio Technology Co., Ltd. Class H has 316,138,700 shares outstanding.
What happened to Jiangsu Recbio Technology Co., Ltd. Class H’s price movement after its last earnings report?
Jiangsu Recbio Technology Co., Ltd. Class H reported an EPS of -HK$0.776 in its last earnings report, expectations of -HK$0.776. Following the earnings report the stock price went down -1.777%.
Which hedge fund is a major shareholder of Jiangsu Recbio Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$7.50 (-1.32% Downside)
HK$7.50 (-1.32% Downside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.60%
12-Months-Change
Fundamentals
Return on Equity
-129.05%
Trailing 12-Months
Asset Growth
-23.60%
Trailing 12-Months
Company Description
Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. Class H (2179) is a biotechnology company based in Jiangsu, China. The company specializes in the research, development, and commercialization of innovative vaccines. Recbio's core products focus on addressing infectious diseases and public health needs, leveraging advanced technologies to create next-generation vaccines that enhance immune responses and safety profiles.
Technical Analysis
TOT BIOPHARM International Co. Ltd.
―
Lepu Biopharma Co. Ltd. Class H
―
CStone Pharmaceuticals
―
SinoMab Bioscience Ltd.
―